Cleared Traditional

K933811 - MORELLE SOS TREATMENT, MORELLE MAMAPLAST, MORELLE ABDOPLAST

K933811 is an FDA 510(k) clearance for MORELLE SOS TREATMENT, manufactured by Pitt Enterprises (Silicone) , Ltd.. The device is a Class 1 General & Plastic Surgery device with product code MDA cleared through the Traditional 510(k) pathway after a 281-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
281d
Days
Class 1
Risk

K933811 is an FDA 510(k) clearance for the MORELLE SOS TREATMENT, MORELLE MAMAPLAST, MORELLE ABDOPLAST. Classified as Elastomer, Silicone, For Scar Management (product code MDA), Class I - General Controls.

Submitted by Pitt Enterprises (Silicone) , Ltd. (New Millford, US). The FDA issued a Cleared decision on May 12, 1994 after a review of 281 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4025 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K933811

510(k) Number K933811 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1993
Decision Date May 12, 1994
Days to Decision 281 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
166d slower than avg
Panel avg: 115d · This submission: 281d
Pathway characteristics
Predicate-based equivalence.

MDA Device Classification - Class 1, General Controls

Product Code MDA Elastomer, Silicone, For Scar Management
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4025
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MDA Elastomer, Silicone, For Scar Management

All 80
Devices cleared under the same product code (MDA) and FDA review panel - the closest regulatory comparables to K933811.
SILK*SKIN SCAR TREATMENT
K941197 · Puritas Health Care, Inc. · Aug 1994
EPI-DERM SILICONE GEL SHEETING
K942156 · Biodermis Corp. · Jun 1994
NOVAGEL SILICONE GEL SHEETING
K941125 · Brennen Medical, Inc. · May 1994
JOBSKIN CONTINUING CARE
K925583 · Jobst Institute, Inc. · Apr 1994
PMT SILICONE SHEETING
K935499 · Pmt Corp. · Feb 1994
HASKON MEDICAL GRADE SHEETING
K934829 · Haskon Intl., Inc. · Feb 1994